Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,428,955
-
Share change
-
+237,138
-
Total reported value
-
$7,319,907,614
-
Put/Call ratio
-
213%
-
Price per share
-
$127.40
-
Number of holders
-
418
-
Value change
-
+$28,041,901
-
Number of buys
-
175
-
Number of sells
-
218
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2021
As of 31 Dec 2021 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 418 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,428,955 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, Polaris Capital Management, LLC, and GOLDMAN SACHS GROUP INC.
This table shows 422 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.